The goals of the proposal are to investigate the regulation of expression of alpha and beta adrenergic receptor subtypes with aging in organs such as the cardiovascular system that have particular relevance to the pathophysiology and pharmacologic treatment of geriatric patients. An extensive body of work has demonstrated that there are important alterations in the physiological effects of catecholamines with increasing age. Exciting recent advances have demonstrated that the effects of catecholamines are mediated via a range of adrenergic receptor subtypes far more diverse than had previously been appreciated. The interplay between the organ-specific expression of these newly described receptor subtypes and possible changes with aging is an important basis for the development of novel drug therapies for the elderly using highly subtype specific adrenergic agonists or antagonists. The first goal of the proposed work is to investigate the distribution of alpha and beta adrenergic receptor subtypes in a number of important organs using molecular biological techniques aimed at quantifying receptor mRNA's and comparing the abundance of these mRNA's across the age range in Fischer 344 rats. Expression of the following genes will be measured: beta1 and beta2; alpha1A, alpha1B and alpha1C; and alpha2A, alpha2B, and alpha2C in a number of important target tissues for catecholamines. The tissues will include: heart, several blood vessels; liver; prostate and bladder; kidney; lung; and brain (cortex and cerebellum). These studies will use Northern blotting or a quantitative application of the polymerase chain reaction to measure particularly rare mRNA's. Results of these studies will be compared with determinations of the amount of receptor protein, assayed either with radioligand binding techniques or with polyclonal rabbit antibodies that will be prepared against peptides specific for the different adrenergic receptor subtypes. The second major goal of the proposal is to investigate the possibility that regulation of these receptor genes is differentially modified by several important pathophysiological states in young versus old rats. In general, with aging there is a decline in the capacity of an organism to respond to pathophysiological perturbations induced by disease or drugs. The effects of excess thyroid hormone on the expression of these genes in the heart and brain of young and old animals will be examined. Also, the effects of a tricyclic antidepressant on the regulation of gene expression in the brains of young and old rats will be compared.

Agency
National Institute of Health (NIH)
Institute
National Institute on Aging (NIA)
Type
Research Project (R01)
Project #
1R01AG009597-01
Application #
3121488
Study Section
Biochemical Endocrinology Study Section (BCE)
Project Start
1991-02-15
Project End
1995-01-31
Budget Start
1991-02-15
Budget End
1992-01-31
Support Year
1
Fiscal Year
1991
Total Cost
Indirect Cost
Name
Stanford University
Department
Type
Schools of Medicine
DUNS #
800771545
City
Stanford
State
CA
Country
United States
Zip Code
94305
Thomas, J M; Hoffman, B B (1996) Isoform-specific sensitization of adenylyl cyclase activity by prior activation of inhibitory receptors: role of beta gamma subunits in transducing enhanced activity of the type VI isoform. Mol Pharmacol 49:907-14
Chin, J H; Okazaki, M; Hu, Z W et al. (1996) Activation of heat shock protein (hsp)70 and proto-oncogene expression by alpha1 adrenergic agonist in rat aorta with age. J Clin Invest 97:2316-23
Chin, J H; Okazaki, M; Frazier, J S et al. (1996) Impaired cAMP-mediated gene expression and decreased cAMP response element binding protein in senescent cells. Am J Physiol 271:C362-71
Hu, Z W; Shi, X Y; Okazaki, M et al. (1995) Angiotensin II induces transcription and expression of alpha 1-adrenergic receptors in vascular smooth muscle cells. Am J Physiol 268:H1006-14
Thomas, J M; Frazier, J S; Hu, Z W et al. (1995) Phosphorylation of cyclic AMP response element-binding protein and induction of c-fos gene expression on withdrawal from chronic treatment with carbachol in NG108-15 cells. Mol Pharmacol 48:593-600
Shilo, L; Chin, J H; Hoffman, B B (1994) Impaired beta-adrenergic receptor-mediated regulation of gene expression in adipocytes from older rats. Am J Physiol 266:E659-65
Sakaue, M; Hoffman, B B (1994) Effects of cell density and conditioned medium on alpha 2A adrenergic receptor density and messenger RNA abundance in HT-29 cells. Life Sci 54:1785-91
Okazaki, M; Hu, Z W; Fujinaga, M et al. (1994) Alpha 1 adrenergic receptor-induced c-fos gene expression in rat aorta and cultured vascular smooth muscle cells. J Clin Invest 94:210-8
Shilo, L; Sakaue, M; Thomas, J M et al. (1994) Enhanced transcription of the human alpha 2A-adrenergic receptor gene by cAMP: evidence for multiple cAMP responsive sequences in the promoter region of this gene. Cell Signal 6:73-82
Thomas, J M; Hoffman, B B (1993) Buprenorphine prevents and reverses the expression of chronic etorphine-induced sensitization of adenylyl cyclase in SK-N-SH human neuroblastoma cells. J Pharmacol Exp Ther 264:368-74

Showing the most recent 10 out of 12 publications